Literature DB >> 7753810

Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA.

M Nakanishi1, G R Adami, R S Robetorye, A Noda, S F Venable, D Dimitrov, O M Pereira-Smith, J R Smith.   

Abstract

p21Sdi1 (also known as Cip1 and Waf1), an inhibitor of DNA synthesis cloned from senescent human fibroblasts, is an inhibitor of G1 cyclin-dependent kinases (Cdks) in vitro and is transcriptionally regulated by wild-type p53. In addition, p21Sdi1 has been found to inhibit DNA replication by direct interaction with proliferating cell nuclear antigen. In this study we analyzed normal human fibroblast cells arrested in G0 and determined that an excess of p21Sdi1 was present after immunodepletion of various cyclins and Cdks, in contrast to mitogen-stimulated cells in early S phase. Expression of antisense p21Sdi1 RNA in G0-arrested cells resulted in induction of DNA synthesis as well as entry into mitosis. These results suggest that p21Sdi1 functions in G0 and early G1 and that decreased expression of the gene is necessary for cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753810      PMCID: PMC41942          DOI: 10.1073/pnas.92.10.4352

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors:  L HAYFLICK
Journal:  Exp Cell Res       Date:  1965-03       Impact factor: 3.905

2.  A cdc2-like protein is involved in the initiation of DNA replication in Xenopus egg extracts.

Authors:  J J Blow; P Nurse
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

Review 3.  G1 events and regulation of cell proliferation.

Authors:  A B Pardee
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

Review 4.  Universal control mechanism regulating onset of M-phase.

Authors:  P Nurse
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

Review 5.  Simple and complex cell cycles.

Authors:  F Cross; J Roberts; H Weintraub
Journal:  Annu Rev Cell Biol       Date:  1989

6.  Hyperinducible gene expression from a metallothionein promoter containing additional metal-responsive elements.

Authors:  J McNeall; A Sánchez; P P Gray; C N Chesterman; M J Sleigh
Journal:  Gene       Date:  1989-03-15       Impact factor: 3.688

7.  Entry into S phase is inhibited in two immortal cell lines fused to senescent human diploid cells.

Authors:  G H Stein; R M Yanishevsky
Journal:  Exp Cell Res       Date:  1979-04       Impact factor: 3.905

8.  p21-containing cyclin kinases exist in both active and inactive states.

Authors:  H Zhang; G J Hannon; D Beach
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

9.  A cyclin associated with the CDK-activating kinase MO15.

Authors:  T P Mäkelä; J P Tassan; E A Nigg; S Frutiger; G J Hughes; R A Weinberg
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

10.  Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells.

Authors:  M Johnson; D Dimitrov; P J Vojta; J C Barrett; A Noda; O M Pereira-Smith; J R Smith
Journal:  Mol Carcinog       Date:  1994-10       Impact factor: 4.784

View more
  28 in total

1.  The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells.

Authors:  W Poluha; D K Poluha; B Chang; N E Crosbie; C M Schonhoff; D L Kilpatrick; A H Ross
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation.

Authors:  Hideo Nishitani; Yasushi Shiomi; Hiroka Iida; Masato Michishita; Toshihiro Takami; Toshiki Tsurimoto
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

Review 3.  The effect of IFNgamma on the hepatocyte: cell cycle and apoptosis.

Authors:  B J Tura; K E Bunyan; D J Harrison
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

4.  Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene.

Authors:  G M Ledda-Columbano; M Pibiri; R Loi; A Perra; H Shinozuka; A Columbano
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 5.  Modelling mammalian cellular quiescence.

Authors:  Guang Yao
Journal:  Interface Focus       Date:  2014-06-06       Impact factor: 3.906

6.  p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.

Authors:  Asmaà Fritah; Cécile Saucier; Jan Mester; Gérard Redeuilh; Michèle Sabbah
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein.

Authors:  G P Dimri; M Nakanishi; P Y Desprez; J R Smith; J Campisi
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  Expression patterns of cytokine, growth factor and cell cycle-related genes after partial hepatectomy in rats with thioacetamide-induced cirrhosis.

Authors:  Shu Yang; Chon Kar Leow; Theresa May Chin Tan
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

9.  Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling.

Authors:  Fumitaka Fujita; Yuko Taniguchi; Takashi Kato; Yasuko Narita; Akiko Furuya; Tatsuhiro Ogawa; Hiroaki Sakurai; Takashi Joh; Makoto Itoh; Mireille Delhase; Michael Karin; Makoto Nakanishi
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Anti-cancer-prostaglandin-induced cell-cycle arrest and its modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump).

Authors:  T Ishikawa; K Akimaru; M Nakanishi; K Tomokiyo; K Furuta; M Suzuki; R Noyori
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.